However, the expression of RIPK3 and MLKL is reduced in various cancer cells, including breast cancer [104], colorectal cancer [105, 106], acute myeloid leukemia [107], and nonsmall cell lung cancer [108]. The gene discussed is RIPK3; the disease is acute myeloid leukemia.